Page 284 - SAHCS HIVMed Journal Vol 20 No 1 2019

Page 10 of 10 Original Research

35. Nachega JB, Mugavero MJ, Zeier M, Vitoria M, Gallant JE. Treatment simplification 47. Sherman GG, Lilian RR, Bhardwaj S, Candy S, Barron P. Laboratory
in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality information system data demonstrate successful implementation of the
of life and decrease healthcare costs. Patient Prefer Adherence. 2011;5:357–367. prevention of mother-to-child transmission programme in South Africa.
https://doi.org/10.2147/PPA.S22771 S Afr Med J. 2014;104(3 Suppl 1):235–238. https://doi.org/10.7196/SAMJ.
36. Grimsrud A, Balkan S, Casas EC, et al. Outcomes of antiretroviral therapy over a 7598
10-year period of expansion: A multicohort analysis of African and Asian HIV 48. Nash D, Wu Y, Elul B, Hoos D, El Sadr W, International Center for AIDS Care and
programs. J Acquir Immune Defic Syndr. 2014;67(2):e55–66. https://doi. Treatment Programs. Program-level and contextual-level determinants of low-
org/10.1097/QAI.0000000000000268 median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan
37. Lewis L, Maughan-Brown B, Grobler A, et al. Impact of home-based HIV testing African countries. AIDS. 2011;25(12):1523–1533. https://doi.org/10.1097/QAD.
services on progress toward the UNAIDS 90-90-90 targets in a hyperendemic area 0b013e32834811b2
of South Africa. J Acquir Immune Defic Syndr. 2019;80(2):135–144. https://doi. 49. Schatz E, Knight L. ‘I was referred from the other side’: Gender and HIV testing
org/10.1097/QAI.0000000000001900 among older South Africans living with HIV. PLoS One. 2018;13(4):e0196158.
38. Sharma M, Barnabas RV, Celum C. Community-based strategies to https://doi.org/10.1371/journal.pone.0196158
strengthen men’s engagement in the HIV care cascade in sub-Saharan Africa. PLoS
Med. 2017;14(4):e1002262. https://doi.org/10.1371/journal.pmed.1002262 50. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa:
Extrapolating prevalence from existing data. Bull World Health Organ.
39. Drain PK, Losina E, Parker G, et al. Risk factors for late-stage HIV disease 2010;88(11):847–853. https://doi.org/10.2471/BLT.10.076349
presentation at initial HIV diagnosis in Durban, South Africa. PLoS One.
2013;8(1):e55305. https://doi.org/10.1371/journal.pone.0055305 51. World Health Organization. Guidelines for managing advanced HIV disease and
rapid initiation of antiretroviral therapy. Geneva: WHO; 2017.
40. Fomundam HN, Tesfay AR, Mushipe SA, et al. Prevalence and predictors of late
presentation for HIV care in South Africa. S Afr Med J. 2017;107(12):1058–1064. 52. Hoffmann CJ, Fielding KL, Charalambous S, et al. Reducing mortality with
https://doi.org/10.7196/SAMJ.2017.v107i12.12358 cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South
Africa. AIDS. 2010;24(11):1709–1716. https://doi.org/10.1097/QAD.0b013e328
41. Geng EH, Hunt PW, Diero LO, et al. Trends in the clinical characteristics of HIV-infected 33ac6bc
patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002
and 2009. J Int AIDS Soc. 2011;14(1):46. https://doi.org/10.1186/1758-2652-14-46 53. Walker AS, Ford D, Gilks CF, et al. Daily co-trimoxazole prophylaxis in severely
42. Lahuerta M, Wu Y, Hoffman S, et al. Advanced HIV disease at entry into HIV care immunosuppressed HIV-infected adults in Africa started on combination
antiretroviral therapy: An observational analysis of the DART cohort. Lancet.
and initiation of antiretroviral therapy during 2006-2011: Findings from four sub- 2010;375(9722):1278–1286. https://doi.org/10.1016/S0140-6736(10)60057-8
saharan African countries. Clin Infect Dis. 2014;58(3):432–441. https://doi.
org/10.1093/cid/cit724 54. Hakim J, Musiime V, Szubert AJ, et al. Enhanced prophylaxis plus antiretroviral
43. Ndawinz JD, Chaix B, Koulla-Shiro S, et al. Factors associated with late antiretroviral therapy for advanced HIV infection in Africa. N Engl J Med. 2017;377(3):233–245.
https://doi.org/10.1056/NEJMoa1615822
therapy initiation in Cameroon: A representative multilevel analysis. J Antimicrob
Chemother. 2013;68(6):1388–1399. https://doi.org/10.1093/jac/dkt011 55. Daviaud E, Chopra M. How much is not enough? Human resources requirements
44. Bor J, Rosen S, Chimbindi N, et al. Mass HIV treatment and sex disparities in life for primary health care: A case study from South Africa. Bull World Health Organ.
2008;86(1):46–51. https://doi.org/10.2471/BLT.07.042283
expectancy: Demographic surveillance in rural South Africa. PLoS Med.
2015;12(11):e1001905; discussion e1001905. https://doi.org/10.1371/journal. 56. Van Rensburg HC. South Africa’s protracted struggle for equal distribution and
pmed.1001905 equitable access – still not there. Hum Resour Health. 2014;12:26. https://doi.
45. Mambanga P, Sirwali RN, Tshitangano T. Factors contributing to men’s reluctance org/10.1186/1478-4491-12-26
to seek HIV counselling and testing at primary health care facilities in Vhembe 57. Willcox ML, Peersman W, Daou P, et al. Human resources for primary health care
district of South Africa. Afr J Prim Health Care Fam Med. 2016;8(2):e1–7. https:// in sub-Saharan Africa: Progress or stagnation? Hum Resour Health. 2015;13:76.
doi.org/10.4102/phcfm.v8i2.996 https://doi.org/10.1186/s12960-015-0073-8
46. Mburu G, Ram M, Siu G, Bitira D, Skovdal M, Holland P. Intersectionality of HIV 58. Bassett IV, Coleman SM, Giddy J, et al. Barriers to care and 1-year mortality among
stigma and masculinity in eastern Uganda: Implications for involving men in HIV newly diagnosed HIV-infected people in Durban, South Africa. J Acquir Immune
programmes. BMC Public Health. 2014;14:1061. https://doi.org/10.1186/1471- Defic Syndr. 2017;74(4):432–438. https://doi.org/10.1097/QAI.0000000000
2458-14-1061 001277

http://www.sajhivmed.org.za 277 Open Access